Zinc finger E-box binding homeobox 1 promotes invasion and bone metastasis of small cell lung cancer in vitro and in vivo

Cancer Science

Volumn 103, Issue 8, 2012, Pages 1420-1428

  Liu, Yi ^a   Zhang, Ning ^a   Wang, Yanxia ^b   Xu, Min ^b   Liu, Na ^a   Pang, Xiaowen ^a   Cao, Jian ^c   Ma, Ningqiang ^a   Pang, Hailin ^a   Liu, Lili ^a   Zhang, Helong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Third Hospital of PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; PARATHYROID HORMONE; UNCLASSIFIED DRUG; ZINC FINGER E-BOX BINDING HOMEOBOX 1; ZINC FINGER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

BLOTTING, WESTERN; BONE NEOPLASMS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENES, HOMEOBOX; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PARATHYROID HORMONE-RELATED PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; SMALL CELL LUNG CARCINOMA; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84864319635     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02347.x     Document Type: Article

References (42)

1. Yano S, Zhang H, Hanibuchi M et al. Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice. Clin Cancer Res 2003; 14: 5380-5.
2. Al Husaini H, Wheatley-Price P, Clemons M, Shepherd FA. Prevention and management of bone metastases in lung cancer: a review. J Thorac Oncol 2009; 4: 251-9.
3. Hirsh V, Major PP, Lipton A et al. Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity. J Thorac Oncol 2008; 3: 228-36.
4. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002; 2: 584-93.
5. Kingsley LA, Fournier PG, Chirgwin JM, Guise TA. Molecular biology of bone metastasis. Mol Cancer Ther 2007; 6: 2609-17.
6. Kozlow W, Guise TA. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia 2005; 10: 169-80.
7. Miki T, Yano S, Hanibuchi M, Sone S. Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice. Oncol Res 2000; 12: 209-17.
8. Zhang H, Yano S, Miki T et al. A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID mice. Clin Exp Metastasis 2003; 20: 153-9.
9. Ma N, Liu L, Min J et al. The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis. Clin Exp Metastasis 2011; 28: 765-78.
10. Liu Y, Zhang Y, Min J et al. Calcineurin promotes proliferation, migration, and invasion of small cell lung cancer. Tumour Biol 2010; 31: 199-207.
11. Spaderna S, Schmalhofer O, Wahlbuhl M et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 2008; 68: 537-44.
12. Mejlvang J, Kriajevska M, Vandewalle C et al. Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol Biol Cell 2007; 18: 4615-24.
13. Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW, Waltham M. Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tissues Organs 2007; 185: 191-203.
14. Yang S, Du J, Wang Z et al. BMP-6 promotes E-cadherin expression through repressing delta EF1 in breast cancer cells. BMC Cancer 2007; 7: 211.
15. Arumugam T, Ramachandran V, Fournier KF et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 2009; 69: 5820-8.
16. Li Y, VandenBoom TG, 2nd, Kong D et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 2009; 69: 6704-12.
17. Takeyama Y, Sato M, Horio M et al. Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Cancer Lett 2010; 296: 216-24.
18. Gemmill RM, Roche J, Potiron VA et al. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett 2011; 300: 66-78.
19. Clarhaut J, Gemmill RM, Potiron VA et al. ZEB1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells. Neoplasia 2009; 11: 157-66.
20. Dohadwala M, Yang SC, Luo J et al. Cyclooxygenase-2-depende nt regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res 2006; 66: 5338-45.
21. Liu N, Bi F, Pan Y et al. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res 2004; 10: 6239-47.
22. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002; 295: 868-72.
23. Wang F, Reierstad S, Fishman D. Over-expression in MCF-7 cells enhances cellular invasiveness and progelatinase activation. Cancer Lett 2005; 236: 292-301.
24. Muguruma H, Yano S, Kakiuchi S et al. Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity. Clin Cancer Res 2005; 11: 8822-8.
25. Miki T, Yano S, Hanibuchi M, Kanematsu T, Muguruma H, Sone S. Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice. Int J Cancer 2004; 108: 511-5.
26. Zhang XH, Wang Q, Gerald W et al. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 2009; 16: 67-78.
27. Pathi SP, Kowalczewski C, Tadipatri R, Fischbach C. A novel 3-D mineralized tumor model to study breast cancer bone metastasis. PLoS One 2010; 5: e8849.
28. Msaouel P, Pissimissis N, Halapas A, Koutsilieris M. Mechanisms of bone metastasis in prostate cancer: clinical implications. Best Pract Res Clin Endocrinol Metab 2008; 22: 341-55.
29. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-28.
30. Tse JC, Kalluri R. Mechanisms of metastasis: epithelial-to-mesen chymal transition and contribution of tumor microenvironment. J Cell Biochem 2007; 101: 816-29.
31. Brabletz T, Hlubek F, Spaderna S et al. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal -epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 2005; 179: 56-65.
32. Spaderna S, Schmalhofer O, Hlubek F et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 2006; 131: 830-40.
33. Yan-Qi Z, Xue-Yan G, Shuang H et al. Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer. Pathology 2007; 39: 470-5.
34. Miyoshi A, Kitajima Y, Kido S et al. Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br J Cancer 2005; 92: 252-8.
35. Lever AM, Strappe PM, Zhao J. Lentiviral vectors. J Biomed Sci 2004; 11: 439-49.
36. Roodman GD. Biology of osteoclast activation in cancer. J Clin Oncol 2001; 19: 3562-71.
37. Orr FW, Lee J, Duivenvoorden WC, Singh G. Pathophysiologic interactions in skeletal metastasis. Cancer 2000; 88: 2912-8.
38. Calbo J, Montfort E, Proost N et al. A fuctional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. Cancer Cell 2011; 19: 244-56.
39. Prudkin L, Liu DD, Ozburn NC et al. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol 2009; 22: 668-78.
40. Cowin P, Rowlands TM, Hatsell SJ. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005; 17: 499-508.
41. Junghans D, Haas IG, Kemler R. Mammalian cadherins and protocadherins: about cell death, synapses and processing. Curr Opin Cell Biol 2005; 17: 446-52.
42. Adachi Y, Takeuchi T, Nagayama T, Ohtsuki Y, Furihata M. Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. FEBS Lett 2009; 583: 430-6.